+1 (858) 255-7854

  • Home
  • Company
  • Products & Solutions
  • Services
  • Contact
  • Shop
  • Terms of Service
  • INVESTORS & PARTNERS
  • More
    • Home
    • Company
    • Products & Solutions
    • Services
    • Contact
    • Shop
    • Terms of Service
    • INVESTORS & PARTNERS
  • Home
  • Company
  • Products & Solutions
  • Services
  • Contact
  • Shop
  • Terms of Service
  • INVESTORS & PARTNERS

How to Invest

Join us to close our Seed Round. Contact us for our due diligence package at contact@aequorinc.com.

How to Partner With Us

Contact us, so we can set up a pilot project at your site.


For any further information, please get in touch with us.

Connect With Us
Aequor Inc.

INVESTMENT OPPORTUNITY

The global green chemicals market size reached USD 121.5 billion in 2022 and is projected to hit around USD 319.45 billion by 2032, poised to grow at a CAGR of 10.20% during forecast period from 2023 to 2032.


Source: Precedence Research

A New Approach to Microbial Control

Aequor has developed a portfolio of 70+ “green” chemical compounds that are more effective than toxic biocides to control bacteria, fungi, and marine fouling at all stages of growth. Current biocide sales aggregate to $600+ billion annually -- but these chemicals are so harmful that their use is being banned and restricted. Companies are being fined for using them.

PROVIDING BREAKTHROUGH SOLUTIONS FOR

Aequor customizes product formulations using its EPA-approved chemicals compounds and provides consulting and testing services to help companies "Go Green" while enjoying significant savings in time, manpower and money and reductions in energy consumption and carbon emissions.


Aequor's early target markets aggregating to US $50 Bn annually, and include:

  • Drop-in chemicals that improve bioethanol production by increasing algae and yeast biomass by over 40%, increasing profits of biofuels and by-products
  • Drop in water treatments that reduce energy consumption, de-clog filters and remove contaminants from all water systems, from major municipalities to rural systems in developing countries
  • Proprietary cleaning products for industrial and institutional services, fulfilling the urgent United Nations One Health goal of combating the spread of antimicrobial resistance through surface enhanced sanitation
  • Propriety personal hygiene, beauty and health products with no carcinogens, endocrine disruptors or other harmful ingredients.

TRACTION - AND VALIDATION

NASA, DOE, and USDA validated the efficacy of Aequor's chemicals for use in water treatments, ethanol production, and surface cleaners. The NIH and DOD selected Aequor for their prestigious accelerator programs to develop new drug candidates. Aequor's subsidiary in London, Aequor Ltd., won a Phase I EU Horizon 2020 grant in the BioMed category. Aequor is a member of several organizations including the Biotechnology Innovation Organization (BIO), Green Chemistry and Commerce Council (GC3), Antimicrobial Resistance Industry Association, various DOD consortia for biodefense, etc. and won the NASA iTech Award in the Life Support category. Aequor was selected by the U.S. government to represent American Innovation at the Global Entrepreneurship Summit 2019 in The Hague.

Aequor Inc.

PRODUCT BENEFITS

Aequor's green, chemicals can replace costly, toxic and ineffective biocides used in thousands of agro-industrial and consumer products and processes.


They work rapidly and save time, manpower, and money, as well as reducing energy consumption and CO2 emissions.

INTELLECTUAL PROPERTY

Founder Cynthia Burzell discovered novel chemical compounds in the ocean that uniquely remove contamination caused by bacteria and fungi including the resistant "Superbugs."

Aequor holds patents in the U.S., Canada, EU and under the PCT on the Composition of Matter and Methods of Use of 30+ novel chemical compounds, and on Methods of Use of the natural marine chemicals and 40+ existing structural analogs, of which 25+ are synthesized, available in commercial quantities, registered as "green," non-toxic, EPA-TSCA approved, and validated for incorporation in multiple delivery systems.

MEET OUR EXPERT TEAM

Founders are Cynthia K. Burzell, Ph.D., CSO and Marilyn J. Bruno, Ph.D., J.D., CEO. Extended team includes CFO Larry Litowitz and 12 proactive Advisors.  K&L Gates LLP, Lee & Hayes, The Acta Group for legal services.

Cynthia K. Burzell

Marilyn J. Bruno

Marilyn J. Bruno

Cynthia K. Burzell

Marilyn J. Bruno

Ph.D., J.D.

Ex-Economic Bureau of US Department of State

Founder & CEO

Cynthia K. Burzell

Cynthia K. Burzell

Cynthia K. Burzell

Cynthia K. Burzell

Cynthia K. Burzell

Ph.D.

Medical and Marine Microbiology

Founder & CSO

Anne Lamsa

Anne Lamsa

Anne Lamsa

Anne Lamsa

Anne Lamsa

Ph.D.

Senior Scientist

Copyright © 2023, Aequor Inc. All Rights Reserved.

  • Terms of Service

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept